Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors(Stage IA-IB)”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Early research (Phase 1)Study completedNCT01494688
What this trial is testing

RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hoffmann-La Roche 217
Early research (Phase 1)Study completedNCT03964233
What this trial is testing

A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)

Who this might be right for
Neoplasms
Boehringer Ingelheim 119
Early research (Phase 1)Looking for participantsNCT05868876
What this trial is testing

A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 205
Early research (Phase 1)Study completedNCT03523819
What this trial is testing

CS1002 in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
CStone Pharmaceuticals 91
Early research (Phase 1)Looking for participantsNCT07086768
What this trial is testing

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid TumorMetastatic Solid Tumor
Lei Zheng 57
Early research (Phase 1)Looking for participantsNCT07092748
What this trial is testing

A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Cancers
Zhejiang Hisun Pharmaceutical Co. Ltd. 110
Early research (Phase 1)Study completedNCT04911894
What this trial is testing

Dose Escalation of IBI321 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 16
Early research (Phase 1)Temporarily pausedNCT03932253
What this trial is testing

MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)

Who this might be right for
Melanoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 79
Early research (Phase 1)Study completedNCT03758001
What this trial is testing

First in Human Study of IBI101 in Chinese Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 38
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Early research (Phase 1)Ended earlyNCT01302405
What this trial is testing

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Prism Pharma Co., Ltd. 23
Early research (Phase 1)Looking for participantsNCT06166888
What this trial is testing

AK131 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Akeso 130
Early research (Phase 1)Looking for participantsNCT06796699
What this trial is testing

A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors With MTAP Gene Deletion
Suzhou Genhouse Bio Co., Ltd. 90
Early research (Phase 1)Looking for participantsNCT06246071
What this trial is testing

TYK-00540 in Adult Patients With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
TYK Medicines, Inc 156
Early research (Phase 1)Study completedNCT05043298
What this trial is testing

A Phase Ia/Ib Clinical Trial of IBI360 Monotherapy or in Combination With Sintilimab and (or) Chemotherapy in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 12
Early research (Phase 1)Looking for participantsNCT06190886
What this trial is testing

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced CancerSolid TumorMetastatic Cancer
Proviva Therapeutics, Inc. 26
Early research (Phase 1)UnknownNCT06386705
What this trial is testing

TSN084 Treating Patients With Advanced Malignant Tumors

Who this might be right for
Malignant Neoplasm
Tyligand Bioscience (Shanghai) Limited 114
Early research (Phase 1)Looking for participantsNCT05907980
What this trial is testing

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Chugai Pharmaceutical 209
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Next Page